The Beauty Health Company (SKIN)

Market Cap	105.93M
Revenue (ttm)	334.29M
Net Income (ttm)	-29.10M
Shares Out	125.25M
EPS (ttm)	-0.36
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	564,715
Open	0.9011
Previous Close	0.8599
Day's Range	0.8351 - 0.9338
52-Week Range	0.9100 - 3.6400
Beta	0.85
Analysts	Hold
Price Target	2.50 (+196.07%)
Earnings Date	May 8, 2025

About SKIN

The Beauty Health Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells esthetic technologies and products in the Americas, the Asia-Pacific, Europe, the Middle East, and Africa. The company’s flagship product is HydraFacial, which enhances the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. It also offers Syndeo devices, which are delivery systems that are designed to connect providers to the consumer’s preferences to create a more personalized experience; consumables...

• Industry: Household & Personal Products
• Sector: Consumer Staples
• Founded: 1997
• Employees: 769
• Stock Exchange: NASDAQ
• Ticker Symbol: SKIN
• Website: https://www.beautyhealth.com

Financial Performance

In 2024, The Beauty Health Company's revenue was $334.29 million, a decrease of -16.00% compared to the previous year's $397.99 million. Losses were -$29.10 million, -70.94% less than in 2023.

Analyst Forecast

According to 5 analysts, the average rating for SKIN stock is "Hold." The 12-month stock price forecast is $2.5, which is an increase of 196.07% from the latest price.

Price Target

$2.5

(196.07% upside)

Analyst Consensus: Hold